Connect with us
BENGALURU: Biocon Limited has launched its glucagon-like peptide-1 therapy, liraglutide, in the Netherlands, marking the first European Union market where the Indian bio-pharmaceutical group is selling...
MUMBAI: If the stock market had a hall of fame for patience, Biocon would deserve a shiny plaque. After two decades since its IPO debut in...
